Site Map . Legal Notices and Privacy Policy .  
 
   OVERVIEW
Board of Directors
Scientific Advisory Board
Investors
Partnerships
   TECHNOLOGY
The NKT Adjuvant Platform
The Cell Adjuvant Platform
More science...
   PRODUCTS
NKT adjuvant products
Cellular adjuvant products
Vaccine and Adjuvant Market
   CONTACTS
Contact us
Access
Job opportunities
   NEWS
Press Releases
Vaccine market
Scientific Articles
Congress
 
Press Releases print this page

2007

01/03/2007 The biotech company Wittycell signs a major license agreement with three world-renowned US universities for a vaccine adjuvant technology.
Download the press release : English version - French version
 
haut de page
  accueil .
© Tous Droits Réservés. ® WITTYCELL v1.0 2006. Dernière modification: 23/12/08
Conception par ® ATRAGENE WCMS 4.0 
Valid HTML 4.01 Transitional